ArticleFrontiers in immunology2026

Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report.

Ke Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.